Regulation of the Bone Vascular Network is Sexually Dimorphic.
BONE QCT/MICROCT
GENETIC ANIMAL MODELS
MATRIX MINERALIZATION
OSTEOBLASTS
PRECLINICAL STUDIES
Journal
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
ISSN: 1523-4681
Titre abrégé: J Bone Miner Res
Pays: United States
ID NLM: 8610640
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
30
01
2019
revised:
11
06
2019
accepted:
24
06
2019
pubmed:
4
7
2019
medline:
4
9
2020
entrez:
4
7
2019
Statut:
ppublish
Résumé
Osteoblast (OB) lineage cells are an important source of vascular endothelial growth factor (VEGF), which is critical for bone growth and repair. During bone development, pubertal differences in males and females exist, but little is known about whether VEGF signaling contributes to skeletal sexual dimorphism. We have found that in mice, conditional disruption of VEGF in osteocalcin-expressing cells (OcnVEGFKO) exerts a divergent influence on morphological, cellular, and whole bone properties between sexes. Furthermore, we describe an underlying sexual divergence in VEGF signaling in OB cultures in vitro independent of circulating sex hormones. High-resolution synchrotron computed tomography and backscattered scanning electron microscopy revealed, in males, extensive unmineralized osteoid encasing enlarged blood vessel canals and osteocyte lacunae in cortical bone after VEGF deletion, which contributed to increased porosity. VEGF was deleted in male and female long bone-derived OBs (OBVEGKO) in vitro and Raman spectroscopic analyses of mineral and matrix repertoires highlighted differences between male and female OBVEGFKO cells, with increased immature phosphate species prevalent in male OBVEGFKO cultures versus wild type (WT). Further sexual dimorphism was observed in bone marrow endothelial cell gene expression in vitro after VEGF deletion and in sclerostin protein expression, which was increased in male OcnVEGFKO bones versus WT. The impact of altered OB matrix composition after VEGF deletion on whole bone geometry was assessed between sexes, although significant differences between OcnVEGFKO and WT were identified only in females. Our results suggest that bone-derived VEGF regulates matrix mineralization and vascularization distinctly in males and females, which results in divergent physical bone traits.
Identifiants
pubmed: 31269275
doi: 10.1002/jbmr.3825
pmc: PMC6899569
doi:
Substances chimiques
Vascular Endothelial Growth Factor A
0
vascular endothelial growth factor A, mouse
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2117-2132Subventions
Organisme : Versus Arthritis
ID : 20984
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R025673/1
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : 20984
Pays : United Kingdom
Informations de copyright
© 2019 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals, Inc.
Références
PLoS One. 2014 Jun 18;9(6):e99946
pubmed: 24940620
J Bone Miner Res. 2003 Dec;18(12):2231-7
pubmed: 14672359
J Clin Invest. 1994 Jun;93(6):2490-6
pubmed: 8200985
J Biol Chem. 2002 Nov 15;277(46):44005-12
pubmed: 12215457
Cell Biochem Funct. 2013 Jan;31(1):1-11
pubmed: 23129289
J Anat. 2012 Jan;220(1):67-76
pubmed: 22050694
J Bone Miner Res. 2007 Oct;22(10):1557-70
pubmed: 17605631
Bone. 2016 Oct;91:30-8
pubmed: 27353702
J Microsc. 2010 Oct;240(1):32-7
pubmed: 21050211
J Bone Miner Res. 2011 Feb;26(2):373-9
pubmed: 20721932
Analyst. 2017 May 30;142(11):1962-1973
pubmed: 28503694
Eur Cell Mater. 2018 May 23;35:281-299
pubmed: 29790567
Arch Med Sci. 2013 Aug 30;9(4):709-12
pubmed: 24049533
Sci Rep. 2017 Oct 16;7(1):13289
pubmed: 29038597
J Cell Physiol. 2008 Feb;214(2):537-44
pubmed: 17685428
Microsc Res Tech. 2014 Dec;77(12):1044-51
pubmed: 25219801
Bone. 2011 Dec;49(6):1242-54
pubmed: 21907838
J Microsc. 2018 Jul;271(1):17-30
pubmed: 29485196
Development. 2002 Apr;129(8):1893-904
pubmed: 11934855
J Bone Miner Res. 2010 Mar;25(3):617-26
pubmed: 19888832
Int J Biochem Cell Biol. 2015 Aug;65:20-31
pubmed: 25997875
J Clin Invest. 2012 Sep;122(9):3101-13
pubmed: 22886301
Horm Res. 1996;45(1-2):74-80
pubmed: 8742123
J Clin Endocrinol Metab. 2001 Oct;86(10):4576-84
pubmed: 11600506
Nature. 2014 Mar 20;507(7492):323-328
pubmed: 24646994
Cytokine. 2009 Jun;46(3):376-81
pubmed: 19394248
J Clin Invest. 2016 Feb;126(2):509-26
pubmed: 26731472
Arch Immunol Ther Exp (Warsz). 2014 Oct;62(5):363-8
pubmed: 24699630
Microsc Res Tech. 2009 Sep;72(9):690-701
pubmed: 19360841
Ann Intern Med. 2010 Mar 16;152(6):380-90
pubmed: 20231569
Dev Cell. 2010 Aug 17;19(2):329-44
pubmed: 20708594
J Musculoskelet Neuronal Interact. 2002 Mar;2(3):209-11
pubmed: 15758435
Bioinformatics. 2013 Apr 15;29(8):1095-7
pubmed: 23422340
J Bone Miner Res. 2012 Mar;27(3):596-609
pubmed: 22162090
Plast Reconstr Surg. 2002 Jun;109(7):2384-97
pubmed: 12045566
Nat Med. 2003 Jun;9(6):669-76
pubmed: 12778165
Lancet. 2002 May 25;359(9320):1841-50
pubmed: 12044392
J Bone Miner Res. 2010 Jul;25(7):1468-86
pubmed: 20533309
Bonekey Rep. 2014 Nov 12;3:585
pubmed: 25396049
Endocrinology. 1997 Jul;138(7):2953-62
pubmed: 9202240
Eur Cell Mater. 2008 May 02;15:100-14
pubmed: 18454418
Arch Pathol. 1972 Aug;94(2):187-91
pubmed: 4114784
J Endocrinol. 2010 Nov;207(2):127-34
pubmed: 20807726
Front Mater. 2017 Sep 13;4:27
pubmed: 29349060
Bone. 2010 Jun;46(6):1564-73
pubmed: 20171304
Bone. 2013 Mar;53(1):120-8
pubmed: 23219945
Nat Rev Drug Discov. 2012 May;11(5):401-19
pubmed: 22543469